Results 11 to 20 of about 24,308 (212)

Wow! I Have Six Fingers!: Would You Accept Structural Changes of Your Hand in VR?

open access: yesFrontiers in Robotics and AI, 2016
-
Ludovic eHoyet   +3 more
doaj   +1 more source

Robots! - Introduction to Engineering and Computer Science [PDF]

open access: yes2016 ASEE Annual Conference & Exposition Proceedings, 2016
For close to three decades, [state] rising sophomore students have had the opportunity to have their first taste of college life while attending the [University Name] Summer High School Institute. For over ten years we have team taught two courses to expose students to computer hardware and software programming techniques. We were challenged to combine
Steven F Barrett   +2 more
openaire   +2 more sources

Reflecting on the Presence of Science Fiction Robots in Computing Literature [PDF]

open access: yesACM Transactions on Human-Robot Interaction, 2019
Depictions of robots and AIs in popular science fiction movies and shows have the potential to showcase visions of Human-Robot Interaction (HRI) to the general public and computer science researchers alike. In contrast, studies on the referral, usage, and appropriation of these portrayals by computer scientists in their research publications is an ...
Mubin, Omar (R17188)   +3 more
openaire   +2 more sources

Learning Computer Science Through Robotics [PDF]

open access: yes1996 Annual Conference Proceedings, 2020
Comment: 6 ...
openaire   +2 more sources

Supporting Survivor‐Centered Care Through Digital Health Integration

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Survivors of childhood cancer face barriers to receiving guideline‐based, long‐term follow‐up care. Two digital tools, Passport for Care (PFC) and Cancer SurvivorLink (SurvivorLink), address complementary gaps by enabling tailored survivorship care plan (SCP) generation, updating, storage, and sharing.
Jordan G. Marchak   +15 more
wiley   +1 more source

Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi   +9 more
wiley   +1 more source

Structural insights into an engineered feruloyl esterase with improved MHET degrading properties

open access: yesFEBS Letters, EarlyView.
A feruloyl esterase was engineered to mimic key features of MHETase, enhancing the degradation of PET oligomers. Structural and computational analysis reveal how a point mutation stabilizes the active site and reshapes the binding cleft, expading substrate scope.
Panagiota Karampa   +5 more
wiley   +1 more source

The ubiquitin ligase RNF115 is required for the clearance of damaged lysosomes

open access: yesFEBS Letters, EarlyView.
Upon lysosomal rupture, an E3 ubiquitin ligase RNF115 translocates from the cytosol to the damaged lysosomal membrane. Moreover, RNF115 depletion impairs the clearance of damaged lysosomes, identifying it as a key regulator of lysosomal quality control.
Sae Nakanaga   +3 more
wiley   +1 more source

Septin 9 PB domains coordinate centrosome positioning and microtubule acetylation to control epithelial polarity

open access: yesFEBS Letters, EarlyView.
Septin 9 polybasic domains couple phosphoinositide‐rich membrane binding to centrosome positioning, Golgi organization, and microtubule acetylation to control epithelial polarity. Their loss disrupts this axis, causing centrosome mispositioning, Golgi fragmentation, reduced microtubule acetylation, and polarity inversion via upregulation of the ...
Ting ting Cai   +4 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy